doi:10.3969/j.issn.1004-583X.2021.06.018

Abstract

CLC Number:

R544.1

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.06.018

https://huicui.hebmu.edu.cn/EN/Y2021/V36/I6/566

Figures/Tables 1

References 25

[1]	Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19. 1 million participants from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants[J]. Lancet, 2017, 389(10064):37-55. doi: 10.1016/S0140-6736(16)31919-5 URL
[2]	Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: A pooled analysis of 1018 population-based measurement studies with 88.6 million participants[J]. Int J Epidemiol, 2018, 47(3):872-883i. doi: 10.1093/ije/dyy016 URL
[3]	Brewster LM, Clark JF, Van Montfrans GA. Is greater tissue activity of creatine kinase the genetic factor increasing hypertension risk in black people of sub-Saharan African descent?[J]. J Hypertens, 2000, 18(11):1537-1544. pmid: 11081764
[4]	Haan YC, Oudman I, Diemer F S, et al. Creatine kinase as a marker of obesity in a multi-ethnic population[J]. Mol Cell Endocrinol, 2017, 442:24-31. doi: 10.1016/j.mce.2016.11.022 URL
[5]	Brewster LM. Creatine kinase, energy reserve, and hypertension: From bench to bedside[J]. Ann Transl Med, 2018, 6(15):292. doi: 10.21037/atm.2018.07.15 pmid: 30211180
[6]	Ingwall JS. Energy metabolism in heart failure and remodelling[J]. Cardiovasc Res, 2008, 81(3):412-419. doi: 10.1093/cvr/cvn301 URL
[7]	Brewster LM. Extracellular creatine kinase may modulate purinergic signalling[J]. Purinergic Signal, 2020, 16(3):305-312. doi: 10.1007/s11302-020-09707-0 URL
[8]	Brewster LM, Fernand J. Creatine kinase is associated with bleeding after myocardial infarction[J]. Open Heart, 2020, 7(2):e001261. doi: 10.1136/openhrt-2020-001261 URL
[9]	Brewster LM, Mairuhu G, Bindraban NR, et al. Creatine kinase activity is associated with blood pressure[J]. Circulation, 2006, 114(19):2034-2039. pmid: 17075013
[10]	Pisoni R, Hamrahian M, Fülöp T. Creatine kinase, sodium retention, and blood pressure: Is there a link?[J]. J Clin Hypertens (Greenwich), 2018, 20(2):342-344. doi: 10.1111/jch.2018.20.issue-2 URL
[11]	Oudman I, Kewalbansingh PV, Van Valkengoed I, et al. Creatine kinase is associated with failure of hypertension treatment[J]. J Hypertens, 2013, 31(5):1025-1031. doi: 10.1097/HJH.0b013e32835f5c29 pmid: 23466941
[12]	Brewster LM, Seedat YK. Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β- adrenergic blockers? A systematic review[J]. BMC Med, 2013, 11:141. doi: 10.1186/1741-7015-11-141 pmid: 23721258
[13]	Brewster LM, Haan YC, Zwinderman AH, et al. Creatine kinase and renal sodium excretion in African and European men on a high sodium diet[J]. J Clin Hypertens (Greenwich), 2018, 76(2):373-380.
[14]	Schiaffino S, Reggiani C. Fiber types in mammalian skeletal muscles[J]. Physiol Rev, 2011, 91(4):1447-1531. doi: 10.1152/physrev.00031.2010 pmid: 22013216
[15]	Brewster LM, Coronel CM, Sluiter W, et al. Ethnic differences in tissue creatine kinase activity: An observational study[J]. PLoS One, 2012, 7(3):e32471. doi: 10.1371/journal.pone.0032471 URL
[16]	Brewster LM, Van Montfrans GA. Creatinine kinase and hypertension[J]. J Clin Hypertens (Greenwich), 2008, 10(6):506. doi: 10.1111/j.1751-7176.2008.tb00001.x URL
[17]	Johnsen SH, Lilleng H, Wilsgaard T, et al. Creatine kinase activity and blood pressure in a normal population: The Tromsø study[J]. J Hypertens, 2011, 29(1):36-42. doi: 10.1097/HJH.0b013e32834068e0 pmid: 21063205
[18]	Yen CH, Wang KT, Lee PY, et al. Gender-differences in the associations between circulating creatine kinase, blood pressure, body mass and non-alcoholic fatty liver disease in asymptomatic Asians[J]. PLoS One, 2017, 12:e0179898.
[19]	Emokpae MA, Nwagbara G. Serum creatine kinase-MB isoenzyme activity among subjects with uncomplicated essential hypertension: Any sex differences[J]. Med Sci(Basel), 2017, 5(2):8.
[20]	Brewster LM, Karamat FA, Van Montfrans GA. Creatine kinase and blood pressure: A systematic review[J]. Med Sci (Basel), 2019, 7(4):58.
[21]	Horjus DL, Bokslag A, Hooijberg F, et al. Creatine kinase and blood pressure in women with a history of early-onset preeclampsia[J]. Pregnancy Hypertens, 2019, 15:118-122. doi: 10.1016/j.preghy.2018.12.009 URL
[22]	Brewster LM, Haan YC, Zwinderman AH, et al. CK (creatine kinase) is associated with cardiovascular hemodynamics: The HELIUS study[J]. Hypertension, 2020, 76(2):373-380. doi: 10.1161/HYPERTENSIONAHA.120.14675 pmid: 32594803
[23]	Oudman I, Clark JF, Brewster LM. The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism: A systematic review[J]. PLoS One, 2013, 8(1):e52879. doi: 10.1371/journal.pone.0052879 URL
[24]	Karamat FA, Oudman I, Haan YC, et al. Creatine kinase inhibition lowers systemic arterial blood pressure in spontaneously hypertensive rats: A randomized controlled trial[J]. J Hypertens, 2016, 34(12):2418-2426. pmid: 27512977
[25]	Fares AK, Deborah LH, Yentl CH, et al. The acute effect of beta-guanidinopropionic acid versus creatine or placebo in healthy men (ABC-trial): A randomized controlled first-in-human trial[J]. Br J Clin Pharmacol, 2017, 83(12):2626-2635. doi: 10.1111/bcp.v83.12 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 25

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Liu Yi, Cui Kun, Liu Chang, Zhao Haotian, Li Li, Xue Hongyuan. Correlation between serum secreted frizzled-related protein 5 and early renal damage in patients with essential hypertension [J]. Clinical Focus, 2023, 38(12): 1073-1077.
[2]	Jiang Ji, Zhu Xiaogang, Jiang Shan, Dawa Zhaba, Cen Qiang. Risk factors of proteinuria in hypertensive people living at high altitude for generations [J]. Clinical Focus, 2023, 38(12): 1086-1090.
[3]	Xu Yang, Xue Ling. Influencing factors for mild cognitive impairment in type H hypertension patients combined with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(10): 887-892.
[4]	. [J]. Clinical Focus, 2023, 38(2): 181-184.
[5]	. [J]. Clinical Focus, 2023, 38(1): 88-92.
[6]	Yin Yikun, Yin Xunwei, Wang Jialin, Sun Junzhi. Impacts of Tai Chi exercise cycle on blood pressure and cardiovascular risk factors in essential hypertension: a systematic review and meta-analysis [J]. Clinical Focus, 2022, 37(7): 599-606.
[7]	An Qinyan, Jiang Rong, Kang Bin, Du Ming, Zhou Renming, Zhao Hongjuan, Duan Yi, Lu Fei, Liu Jinming. Levels and clinical significance of RDW, NT-proBNP, BigET-1, HMGB1 in patients with idiopathic pulmonary arterial hypertension [J]. Clinical Focus, 2021, 36(11): 1001-1004.
[8]	. [J]. Clinical Focus, 2021, 36(8): 744-748.
[9]	Gong Tao, Hu Yueyuan, Gao Yun, Guo Chang, Shen Huinan, Wang Dongyu. Relationship between H-type hypertension and severity of neurological deficit in early acute cerebral infarction of LAA [J]. Clinical Focus, 2021, 36(7): 612-615.
[10]	. [J]. Clinical Focus, 2021, 36(3): 270-276.
[11]	Liu Xiaoteng, Shan Weichao, Hou Ruitian, Lin Jinping, Gao Yu, Jin Fengbiao, Liu Chang. Correlation between serum hypersensitive C-reactive protein, lipoprotein-related phospholipase A₂and senile essential hypertension complicated with type 2 diabetes [J]. Clinical Focus, 2021, 36(1): 25-29.
[12]	Liang Yuling, Li Wenxi, Gu Xuewen. Randomized controlled trial of Tianma Gouteng Decoction and irbesartan in treatment of essential hypertension [J]. Clinical Focus, 2020, 35(12): 1097-1100.
[13]	Zhu Bin;Wang Yongxia. Correlation between carotid plaque and blood pressure variation in patients with hypertension [J]. Clinical Focus, 2015, 30(12): 1360-1362.
[14]	Quan Feng;Fan Xuemei;Fang Wenlong. Clinical study of systemic lupus erythematosus associated pulmonary hypertension [J]. Clinical Focus, 2015, 30(12): 1402-1.40414e+007.
[15]	Wang Hongyi. Screening of secondary hypertension [J]. Clinical Focus, 2015, 30(11): 1202-1205.